Search

Iomai Gets Small DoD Grant for Patch-based Anthrax Vaccine

Iomai Corp. [IOMI] says it has won a one-year cost-reimbursement grant for up to $943,856 from the Army Medical Research and Materiel Command to perform preclinical work on a patch-based version of the anthrax vaccine. Iomai will use vaccine antigen developed by United Kingdom-based Avecia Biologics Ltd. and apply its technology to formulate a dry version of the antigen that can be combined with an Iomai adjuvant on a needle-free patch. Iomai will then evaluate the stability of the patch…

Subscriber-only content. Please log in below.

Not a subscriber or registered user yet?

Please contact us at clientservices@accessintel.com or call us at 888-707-5814 (Monday – Thursday 9:00 a.m. – 5:30 p.m. and Friday 9:00 a.m. – 3:00 p.m. ET.), to start a free trial, get pricing information, order a reprint, or post an article link on your website.



Congress Updates

House Republicans Block Measure To Impeach Hegseth

House Republicans on Tuesday evening voted to block an attempt to impeach Defense Secretary Pete Hegseth. In a 211-204 vote, the House moved to refer Rep. Thomas Massie’s (R-Ky.) articles […]


Top House Defense Appropriator Calvert Officially Wins Reelection Bid

Rep. Ken Calvert (R-Calif.), House Republicans’ top defense appropriator, has officially won his reelection bid.  Calvert was running for a redistricted seat against fellow House Republican Rep. Young Kim (R-Calif.), […]


No Path To Defense Reconciliation, Including GOP’s $350 Billion, Coons Says

Top Senate Democrats threw cold water on any GOP plans for a $350 billion fiscal 2027 reconciliation bill, or any defense reconciliation bill, before a new Congress is sworn in […]


Industry Groups ‘Urge’ Congress To Block Stock Buyback Restriction From Final FY ‘27 NDAA

More than three dozen industry associations on Monday called on congressional defense committee leaders to scrap a provision in the final version of the next National Defense Authorization Act that […]